{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:44:29Z","timestamp":1790667869242,"version":"4.1.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,30]]},"DOI":"10.7759\/cureus.106154","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T22:37:14Z","timestamp":1774910234000},"source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and Safety of Laser-Based Therapies for Melasma: A Systematic Review and Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Nora N","family":"Aljoaib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Baltoyour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majda","family":"Al-Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadil  E","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M","family":"Alsharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taif H","family":"Alotbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Retal H","family":"Maghazel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ohoud S","family":"Alqarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahad A","family":"Alsayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Refan F","family":"Alkhalagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham A","family":"Najmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badr A","family":"Altowerki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sultan T","family":"Alluhaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layan A","family":"Alrehaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjprs.2023.06.001","article-title":"Efficacy, effectiveness, and safety of combination laser and tranexamic acid treatment for melasma: a meta-analysis","volume":"5","author":"Adelia AL","year":"2023","unstructured":"Adelia AL, Nurainiwati SA, Putra PYP, Hapsari AS. Efficacy, effectiveness, and safety of combination laser and tranexamic acid treatment for melasma: a meta-analysis. Chin J Plast Reconstr Surg. 2023, 5:154-8. 10.1016\/j.cjprs.2023.06.001","journal-title":"Chin J Plast Reconstr Surg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-15130-9_60","article-title":"Melasma","author":"Dessinioti C","year":"2023","unstructured":"Dessinioti C, Lotti TM, Stratigos AJ, Damevska K, Katsambas AD. Melasma. European Handbook of Dermatological Treatments. Katsambas AD, Lotti TM, Dessinioti C, D'Erme AM (ed): Springer Nature, Switzerland; 2023. 651-61. 10.1007\/978-3-031-15130-9_60"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.16006","article-title":"Efficacy and safety of laser-related therapy for melasma: a systematic review and network meta-analysis","volume":"22","author":"Ma W","year":"2023","unstructured":"Ma W, Gao Q, Liu J, et al.. Efficacy and safety of laser-related therapy for melasma: a systematic review and network meta-analysis. J Cosmet Dermatol. 2023, 22:2910-24. 10.1111\/jocd.16006","journal-title":"J Cosmet Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-023-03810-5","article-title":"Effectiveness of laser and topical tranexamic acid combination therapy in melasma: an updated systematic review and meta-analysis of randomized controlled trials","volume":"38","author":"Khan QA","year":"2023","unstructured":"Khan QA, Abdi P, Farkouh C, et al.. Effectiveness of laser and topical tranexamic acid combination therapy in melasma: an updated systematic review and meta-analysis of randomized controlled trials. Lasers Med Sci. 2023, 38:139. 10.1007\/s10103-023-03810-5","journal-title":"Lasers Med Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-022-03514-2","article-title":"Laser therapy in the treatment of melasma: a systematic review and meta-analysis","volume":"37","author":"Lai D","year":"2022","unstructured":"Lai D, Zhou S, Cheng S, Liu H, Cui Y. Laser therapy in the treatment of melasma: a systematic review and meta-analysis. Lasers Med Sci. 2022, 37:2099-110. 10.1007\/s10103-022-03514-2","journal-title":"Lasers Med Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.25056\/jcm.2024.8.2.81","article-title":"Comparative efficacy of chemical peels and laser treatments in melasma: a meta-analysis of randomized controlled trials","volume":"8","author":"Lee I","year":"2024","unstructured":"Lee I, Kang S, Lee J, Cho H, Lee KW, Lim D. Comparative efficacy of chemical peels and laser treatments in melasma: a meta-analysis of randomized controlled trials. J Cosmet Med. 2024, 8:81-7. 10.25056\/jcm.2024.8.2.81","journal-title":"J Cosmet Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58070936","article-title":"The low-fluence Q-switched ND:YAG laser treatment for melasma: a systematic review","volume":"58","author":"Lee YS","year":"2022","unstructured":"Lee YS, Lee YJ, Lee JM, Han TY, Lee JH, Choi JE. The low-fluence Q-switched ND:YAG laser treatment for melasma: a systematic review. Medicina (Kaunas). 2022, 58:936. 10.3390\/medicina58070936","journal-title":"Medicina (Kaunas)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2017.01.004","article-title":"A review of laser and light therapy in melasma","volume":"3","author":"Trivedi MK","year":"2017","unstructured":"Trivedi MK, Yang FC, Cho BK. A review of laser and light therapy in melasma. Int J Womens Dermatol. 2017, 3:11-20. 10.1016\/j.ijwd.2017.01.004","journal-title":"Int J Womens Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000003775","article-title":"Efficacy and safety of picosecond laser in the treatment of melasma: a network meta-analysis","volume":"49","author":"Ren R","year":"2023","unstructured":"Ren R, Bao S, Qian W, Zhao H. Efficacy and safety of picosecond laser in the treatment of melasma: a network meta-analysis. Dermatol Surg. 2023, 49:S49-55. 10.1097\/DSS.0000000000003775","journal-title":"Dermatol Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-013-1318-1","article-title":"Melasma and laser treatment: an evidenced-based analysis","volume":"29","author":"Halachmi S","year":"2014","unstructured":"Halachmi S, Haedersdal M, Lapidoth M. Melasma and laser treatment: an evidenced-based analysis. Lasers Med Sci. 2014, 29:589-98. 10.1007\/s10103-013-1318-1","journal-title":"Lasers Med Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15270","article-title":"Single and combined 1064\u2009nm Q-switched Nd: YAG laser therapy in melasma: a meta-analysis","volume":"21","author":"Zhang B","year":"2022","unstructured":"Zhang B, Xie B, Shen Y, Zhang L, Song X. Single and combined 1064\u2009nm Q-switched Nd: YAG laser therapy in melasma: a meta-analysis. J Cosmet Dermatol. 2022, 21:3794-802. 10.1111\/jocd.15270","journal-title":"J Cosmet Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15126","article-title":"Efficacy of low-fluence 1064\u2009nm Q-switched Nd: YAG laser for the treatment of melasma: a meta-analysis and systematic review","volume":"21","author":"Chen J","year":"2022","unstructured":"Chen J, Yu N, Peng L, Li H, Tang Y, Ou S, Zhu H. Efficacy of low-fluence 1064\u2009nm Q-switched Nd: YAG laser for the treatment of melasma: a meta-analysis and systematic review. J Cosmet Dermatol. 2022, 21:10.1111\/jocd.15126","journal-title":"J Cosmet Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/001316446002000104","article-title":"A coefficient of agreement for nominal scales","volume":"20","author":"Cohen J","year":"1960","unstructured":"Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960, 20:37-46. 10.1177\/001316446002000104","journal-title":"Educ Psychol Meas"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:l4898. 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref16","unstructured":"The R Project for Statistical Computing. (2025). https.\/\/www.R-project.org\/."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-97-6980-3","article-title":"","author":"Srinivasan A","year":"2024","unstructured":"Srinivasan A, Mishra A, Kumar-M P. R for Basic Biostatistics in Medical Research. Springer, Singapore; 2024. 10.1007\/978-981-97-6980-3"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian R","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986, 7:177-88. 10.1016\/0197-2456(86)90046-2","journal-title":"Control Clin Trials"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne DR","year":"2002","unstructured":"Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol. 2002, 31:140-9. 10.1093\/ije\/31.1.140","journal-title":"Int J Epidemiol"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins JP","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003, 327:557-60.","journal-title":"BMJ"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-010247","article-title":"Plea for routinely presenting prediction intervals in meta-analysis","volume":"6","author":"IntHout J","year":"2016","unstructured":"IntHout J, Ioannidis JP, Rovers MM, Goeman JJ. Plea for routinely presenting prediction intervals in meta-analysis. BMJ Open. 2016, 6:e010247. 10.1136\/bmjopen-2015-010247","journal-title":"BMJ Open"},{"key":"ref22","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg CB","year":"1994","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994, 50:1088-101.","journal-title":"Biometrics"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger M","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997, 315:629-34. 10.1136\/bmj.315.7109.629","journal-title":"BMJ"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2307\/1266219","article-title":"Estimation of error rates in discriminant analysis","volume":"10","author":"Lachenbruch PA","year":"1968","unstructured":"Lachenbruch PA, Mickey MR. Estimation of error rates in discriminant analysis. Technometrics. 1968, 10:1-11. 10.2307\/1266219","journal-title":"Technometrics"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt GH","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Sch\u00fcnemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008, 336:924-6. 10.1136\/bmj.39489.470347.AD","journal-title":"BMJ"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1708847","article-title":"A comparative study between oral tranexamic acid versus oral tranexamic acid and Q-switched Nd-YAG laser in melasma treatment: a clinical and dermoscopic evaluation","volume":"32","author":"Agamia N","year":"2021","unstructured":"Agamia N, Apalla Z, Salem W, Abdallah W. A comparative study between oral tranexamic acid versus oral tranexamic acid and Q-switched Nd-YAG laser in melasma treatment: a clinical and dermoscopic evaluation. J Dermatolog Treat. 2021, 32:819-26. 10.1080\/09546634.2019.1708847","journal-title":"J Dermatolog Treat"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.15171\/jlms.2017.01","article-title":"Combination of Q-switched Nd:YAG and fractional erbium:YAG lasers in treatment of melasma: a randomized controlled clinical trial","volume":"8","author":"Alavi S","year":"2017","unstructured":"Alavi S, Abolhasani E, Asadi S, Nilforoushzadeh M. Combination of Q-switched Nd:YAG and fractional erbium:YAG lasers in treatment of melasma: a randomized controlled clinical trial. J Lasers Med Sci. 2017, 8:1-6. 10.15171\/jlms.2017.01","journal-title":"J Lasers Med Sci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4725.2003.29009.x","article-title":"Combined ultrapulse CO2 laser and Q-switched alexandrite laser compared with Q-switched alexandrite laser alone for refractory melasma: split-face design","volume":"29","author":"Angsuwarangsee S","year":"2003","unstructured":"Angsuwarangsee S, Polnikorn N. Combined ultrapulse CO2 laser and Q-switched alexandrite laser compared with Q-switched alexandrite laser alone for refractory melasma: split-face design. Dermatol Surg. 2003, 29:59-64. 10.1046\/j.1524-4725.2003.29009.x","journal-title":"Dermatol Surg"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S147413","article-title":"Fractional erbium-doped yttrium aluminum garnet laser-assisted drug delivery of hydroquinone in the treatment of melasma","volume":"11","author":"Badawi AM","year":"2018","unstructured":"Badawi AM, Osman MA. Fractional erbium-doped yttrium aluminum garnet laser-assisted drug delivery of hydroquinone in the treatment of melasma. Clin Cosmet Investig Dermatol. 2018, 11:13-20. 10.2147\/CCID.S147413","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.4103\/0974-2077.104915","article-title":"A comparison of low-fluence 1064-nm Q-switched Nd: YAG laser with topical 20% azelaic acid cream and their combination in melasma in Indian patients","volume":"5","author":"Bansal C","year":"2012","unstructured":"Bansal C, Naik H, Kar HK, Chauhan A. A comparison of low-fluence 1064-nm Q-switched Nd: YAG laser with topical 20% azelaic acid cream and their combination in melasma in Indian patients. J Cutan Aesthet Surg. 2012, 5:266-72. 10.4103\/0974-2077.104915","journal-title":"J Cutan Aesthet Surg"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04086.x","article-title":"Split-face study of melasma patients treated with non-ablative fractionated photothermolysis (1540 nm)","volume":"26","author":"Barysch MJ","year":"2012","unstructured":"Barysch MJ, R\u00fcmmelein B, Kolm I, Karpova MB, Sch\u00f6newolf N, Bogdan Allemann I, Dummer R. Split-face study of melasma patients treated with non-ablative fractionated photothermolysis (1540 nm). J Eur Acad Dermatol Venereol. 2012, 26:423-30. 10.1111\/j.1468-3083.2011.04086.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14496","article-title":"Comparison of efficacy and safety of tranexamic acid mesotherapy versus oral tranexamic acid in patients with melasma undergoing Q-switched fractional 1064-nm Nd:YAG laser: A blinded RCT and follow-up","volume":"21","author":"Behrangi E","year":"2022","unstructured":"Behrangi E, Shemshadi M, Ghassemi M, Goodarzi A, Dilmaghani S. Comparison of efficacy and safety of tranexamic acid mesotherapy versus oral tranexamic acid in patients with melasma undergoing Q-switched fractional 1064-nm Nd:YAG laser: A blinded RCT and follow-up. J Cosmet Dermatol. 2022, 21:279-89. 10.1111\/jocd.14496","journal-title":"J Cosmet Dermatol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1080\/14764172.2017.1376098","article-title":"Effects of a fractional picosecond 1,064\u2009nm laser for the treatment of dermal and mixed type melasma","volume":"20","author":"Chalermchai T","year":"2018","unstructured":"Chalermchai T, Rummaneethorn P. Effects of a fractional picosecond 1,064\u2009nm laser for the treatment of dermal and mixed type melasma. J Cosmet Laser Ther. 2018, 20:134-9. 10.1080\/14764172.2017.1376098","journal-title":"J Cosmet Laser Ther"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/srt.70177","article-title":"Fractional and non-fractional picosecond ND:YAG lasers combined with fractional picosecond KTP laser for the treatment of melasma in female Chinese","volume":"31","author":"Chen C","year":"2025","unstructured":"Chen C, Ke Y. Fractional and non-fractional picosecond ND:YAG lasers combined with fractional picosecond KTP laser for the treatment of melasma in female Chinese. Skin Res Technol. 2025, 31:e70177. 10.1111\/srt.70177","journal-title":"Skin Res Technol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.22735","article-title":"Efficacy and safety of a novel picosecond laser using combination of 1\u2009064 and 595\u2009nm on patients with melasma: a prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial","volume":"49","author":"Choi YJ","year":"2017","unstructured":"Choi YJ, Nam JH, Kim JY, et al.. Efficacy and safety of a novel picosecond laser using combination of 1\u2009064 and 595\u2009nm on patients with melasma: a prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial. Lasers Surg Med. 2017, 49:899-907. 10.1002\/lsm.22735","journal-title":"Lasers Surg Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12760","article-title":"Low-fluence Q-switched Nd:YAG laser for the treatment of melasma in Asian patients","volume":"17","author":"Choi JE","year":"2018","unstructured":"Choi JE, Lee DW, Seo SH, Ahn HH, Kye YC. Low-fluence Q-switched Nd:YAG laser for the treatment of melasma in Asian patients. J Cosmet Dermatol. 2018, 17:1053-8. 10.1111\/jocd.12760","journal-title":"J Cosmet Dermatol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3109\/14764172.2014.957217","article-title":"Retrospective analysis of melasma treatment using a dual mode of low-fluence Q-switched and long-pulse Nd:YAG laser vs. low-fluence Q-switched Nd:YAG laser monotherapy","volume":"17","author":"Choi CP","year":"2015","unstructured":"Choi CP, Yim SM, Seo SH, Ahn HH, Kye YC, Choi JE. Retrospective analysis of melasma treatment using a dual mode of low-fluence Q-switched and long-pulse Nd:YAG laser vs. low-fluence Q-switched Nd:YAG laser monotherapy. J Cosmet Laser Ther. 2015, 17:2-8. 10.3109\/14764172.2014.957217","journal-title":"J Cosmet Laser Ther"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15229","article-title":"A split face randomized controlled trial comparing 1,064\u00a0nm Q-switched Nd-YAG laser and modified Kligman's formulation in patients with melasma in darker skin","volume":"59","author":"Dev T","year":"2020","unstructured":"Dev T, Sreenivas V, Sharma VK, Sahni K, Bhari N, Sethuraman G. A split face randomized controlled trial comparing 1,064\u00a0nm Q-switched Nd-YAG laser and modified Kligman's formulation in patients with melasma in darker skin. Int J Dermatol. 2020, 59:1525-30. 10.1111\/ijd.15229","journal-title":"Int J Dermatol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14140","article-title":"Oral tranexamic acid, hydroquinone 4% and low-fluence 1064 nm Q-switched Nd:YAG laser for mixed melasma: clinical and dermoscopic evaluation","volume":"21","author":"Elkamshoushi AM","year":"2022","unstructured":"Elkamshoushi AM, Romisy D, Omar SS. Oral tranexamic acid, hydroquinone 4% and low-fluence 1064 nm Q-switched Nd:YAG laser for mixed melasma: clinical and dermoscopic evaluation. J Cosmet Dermatol. 2022, 21:657-68. 10.1111\/jocd.14140","journal-title":"J Cosmet Dermatol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.23441","article-title":"Combining low power fractional CO(2) with QS-NdYAG toning in the treatment of melasma reduces the incidence of punctate leukoderma","volume":"53","author":"Esmat S","year":"2021","unstructured":"Esmat S, Z Elramly A, Shahin D, Hilal RF. Combining low power fractional CO(2) with QS-NdYAG toning in the treatment of melasma reduces the incidence of punctate leukoderma. Lasers Surg Med. 2021, 53:1325-40. 10.1002\/lsm.23441","journal-title":"Lasers Surg Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.22263","article-title":"A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064\u2009nm) laser versus low-fluence Q-switched alexandrite laser (755\u2009nm) for the treatment of facial melasma","volume":"46","author":"Fabi SG","year":"2014","unstructured":"Fabi SG, Friedmann DP, Niwa Massaki AB, Goldman MP. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064\u2009nm) laser versus low-fluence Q-switched alexandrite laser (755\u2009nm) for the treatment of facial melasma. Lasers Surg Med. 2014, 46:531-7. 10.1002\/lsm.22263","journal-title":"Lasers Surg Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.12253","article-title":"Long-term results in low-fluence 1064-nm Q-switched Nd:YAG laser for melasma: is it effective?","volume":"15","author":"Gokalp H","year":"2016","unstructured":"Gokalp H, Akkaya AD, Oram Y. Long-term results in low-fluence 1064-nm Q-switched Nd:YAG laser for melasma: is it effective?. J Cosmet Dermatol. 2016, 15:420-6. 10.1111\/jocd.12253","journal-title":"J Cosmet Dermatol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000653","article-title":"Clinical and histopathologic assessment of facial melasma after low-fluence Q-switched neodymium-doped yttrium aluminium garnet laser","volume":"42","author":"Hofbauer Parra CA","year":"2016","unstructured":"Hofbauer Parra CA, Careta MF, Valente NY, de Sanches Os\u00f3rio NE, Torezan LA. Clinical and histopathologic assessment of facial melasma after low-fluence Q-switched neodymium-doped yttrium aluminium garnet laser. Dermatol Surg. 2016, 42:507-12. 10.1097\/DSS.0000000000000653","journal-title":"Dermatol Surg"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3109\/14764172.2012.655287","article-title":"Split-face comparative study of 1550 nm fractional photothermolysis and trichloroacetic acid 15% chemical peeling for facial melasma in Asian skin","volume":"14","author":"Hong SP","year":"2012","unstructured":"Hong SP, Han SS, Choi SJ, et al.. Split-face comparative study of 1550 nm fractional photothermolysis and trichloroacetic acid 15% chemical peeling for facial melasma in Asian skin. J Cosmet Laser Ther. 2012, 14:81-6. 10.3109\/14764172.2012.655287","journal-title":"J Cosmet Laser Ther"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.23440","article-title":"Efficacy and safety of topical silymarin versus low fluence 1064-nm Q switched ND:YAG laser in the treatment of melasma: a comparative randomized trial","volume":"53","author":"Ibrahim SM","year":"2021","unstructured":"Ibrahim SM, Farag AS, Ali MS, El-Gendy WM. Efficacy and safety of topical silymarin versus low fluence 1064-nm Q switched ND:YAG laser in the treatment of melasma: a comparative randomized trial. Lasers Surg Med. 2021, 53:1341-7. 10.1002\/lsm.23440","journal-title":"Lasers Surg Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-014-0080-x","article-title":"Low-power fractional CO\u2082 laser versus low-fluence Q-switch 1,064 nm Nd:YAG laser for treatment of melasma: a randomized, controlled, split-face study","volume":"15","author":"Jalaly NY","year":"2014","unstructured":"Jalaly NY, Valizadeh N, Barikbin B, Yousefi M. Low-power fractional CO\u2082 laser versus low-fluence Q-switch 1,064 nm Nd:YAG laser for treatment of melasma: a randomized, controlled, split-face study. Am J Clin Dermatol. 2014, 15:357-63. 10.1007\/s40257-014-0080-x","journal-title":"Am J Clin Dermatol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2010.01523.x","article-title":"Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream","volume":"36","author":"Jeong SY","year":"2010","unstructured":"Jeong SY, Shin JB, Yeo UC, Kim WS, Kim IH. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream. Dermatol Surg. 2010, 36:909-18. 10.1111\/j.1524-4725.2010.01523.x","journal-title":"Dermatol Surg"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2019.31.2.133","article-title":"A face-split study to evaluate the effects of microneedle radiofrequency with Q-switched ND:YAG laser for the treatment of melasma","volume":"31","author":"Jung JW","year":"2019","unstructured":"Jung JW, Kim WO, Jung HR, Kim SA, Ryoo YW. A face-split study to evaluate the effects of microneedle radiofrequency with Q-switched ND:YAG laser for the treatment of melasma. Ann Dermatol. 2019, 31:133-8. 10.5021\/ad.2019.31.2.133","journal-title":"Ann Dermatol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04100.x","article-title":"Is non-ablative 1550-nm fractional photothermolysis an effective modality to treat melasma? Results from a prospective controlled single-blinded trial in 51 patients","volume":"26","author":"Karsai S","year":"2012","unstructured":"Karsai S, Fischer T, Pohl L, Schmitt L, Buhck H, J\u00fcnger M, Raulin C. Is non-ablative 1550-nm fractional photothermolysis an effective modality to treat melasma? Results from a prospective controlled single-blinded trial in 51 patients. J Eur Acad Dermatol Venereol. 2012, 26:470-6. 10.1111\/j.1468-3083.2011.04100.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.59796\/jcst.V14N2.2024.41","article-title":"Comparative effectiveness of 20% azelaic acid with 1064-nm ND:YAG picosecond laser vs azelaic acid alone for melasma treatment in Thai female patients: a split-face study","volume":"14","author":"Klaisung N","year":"2024","unstructured":"Klaisung N, Sajjachareonpong P, Thongkaow S, Dornphai P, Tienthavorn T. Comparative effectiveness of 20% azelaic acid with 1064-nm ND:YAG picosecond laser vs azelaic acid alone for melasma treatment in Thai female patients: a split-face study. JCST. 2024, 14:41. 10.59796\/jcst.V14N2.2024.41","journal-title":"JCST"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2018.30.1.1","article-title":"Treatment of melasma with pulsed-dye laser and 1,064-nm Q-switched Nd:YAG laser: a split-face study","volume":"30","author":"Kong SH","year":"2018","unstructured":"Kong SH, Suh HS, Choi YS. Treatment of melasma with pulsed-dye laser and 1,064-nm Q-switched Nd:YAG laser: a split-face study. Ann Dermatol. 2018, 30:1-7. 10.5021\/ad.2018.30.1.1","journal-title":"Ann Dermatol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.01.048","article-title":"Nonablative 1550-nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled pilot study","volume":"64","author":"Kroon MW","year":"2011","unstructured":"Kroon MW, Wind BS, Beek JF, van der Veen JP, Nieuweboer-Krobotov\u00e1 L, Bos JD, Wolkerstorfer A. Nonablative 1550-nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled pilot study. J Am Acad Dermatol. 2011, 64:516-23. 10.1016\/j.jaad.2010.01.048","journal-title":"J Am Acad Dermatol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1080\/14764172.2018.1427869","article-title":"Topical 3% tranexamic acid enhances the efficacy of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the treatment of melasma","volume":"20","author":"Laothaworn V","year":"2018","unstructured":"Laothaworn V, Juntongjin P. Topical 3% tranexamic acid enhances the efficacy of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the treatment of melasma. J Cosmet Laser Ther. 2018, 20:320-5. 10.1080\/14764172.2018.1427869","journal-title":"J Cosmet Laser Ther"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2013.848261","article-title":"A comparative study of low-fluence 1064-nm Q-switched Nd:YAG laser with or without chemical peeling using Jessner's solution in melasma patients","volume":"25","author":"Lee DB","year":"2014","unstructured":"Lee DB, Suh HS, Choi YS. A comparative study of low-fluence 1064-nm Q-switched Nd:YAG laser with or without chemical peeling using Jessner's solution in melasma patients. J Dermatolog Treat. 2014, 25:523-8. 10.3109\/09546634.2013.848261","journal-title":"J Dermatolog Treat"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-018-2529-2","article-title":"A split-face study: comparison of picosecond alexandrite laser and Q-switched Nd:YAG laser in the treatment of melasma in Asians","volume":"33","author":"Lee MC","year":"2018","unstructured":"Lee MC, Lin YF, Hu S, Huang YL, Chang SL, Cheng CY, Chang CS. A split-face study: comparison of picosecond alexandrite laser and Q-switched Nd:YAG laser in the treatment of melasma in Asians. Lasers Med Sci. 2018, 33:1733-8. 10.1007\/s10103-018-2529-2","journal-title":"Lasers Med Sci"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/5961152","article-title":"The efficacy and safety of a low-fluence 1064 nm picosecond Nd-YAG laser compared with those of a low-fluence photoacoustic therapy pulsed (PTP) Mode 1064 nm Q-switched Nd-YAG laser for treatment of melasma: a prospective split-face study","author":"Lee SY","year":"2023","unstructured":"Lee SY, Kim HR, Park JS, et al.. The efficacy and safety of a low-fluence 1064 nm picosecond Nd-YAG laser compared with those of a low-fluence photoacoustic therapy pulsed (PTP) Mode 1064 nm Q-switched Nd-YAG laser for treatment of melasma: a prospective split-face study. Dermatol Ther. 2023, 5961152. 10.1155\/2023\/5961152","journal-title":"Dermatol Ther"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2008.34130.x","article-title":"Efficacy and safety of intense pulsed light in treatment of melasma in Chinese patients","volume":"34","author":"Li YH","year":"2008","unstructured":"Li YH, Chen JZ, Wei HC, et al.. Efficacy and safety of intense pulsed light in treatment of melasma in Chinese patients. Dermatol Surg. 2008, 34:693-700; discussion 700-1. 10.1111\/j.1524-4725.2008.34130.x","journal-title":"Dermatol Surg"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1132823","article-title":"Comparison of the efficacy and safety of picosecond Nd:YAG laser (1,064\u2009nm), picosecond alexandrite laser (755\u2009nm) and 2% hydroquinone cream in the treatment of melasma: a randomized, controlled, assessor-blinded trial","volume":"10","author":"Liang S","year":"2023","unstructured":"Liang S, Shang S, Zhang W, Tan A, Zhou B, Mei X, Li L. Comparison of the efficacy and safety of picosecond Nd:YAG laser (1,064\u2009nm), picosecond alexandrite laser (755\u2009nm) and 2% hydroquinone cream in the treatment of melasma: a randomized, controlled, assessor-blinded trial. Front Med (Lausanne). 2023, 10:1132823. 10.3389\/fmed.2023.1132823","journal-title":"Front Med (Lausanne)"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1007\/s10103-025-04286-1","article-title":"Comparative efficacy and safety of the novel Picosecond Alexandrite Laser and the traditional combined Q-switched and long-pulse Nd: YAG lasers in melasma treatment: a randomized evaluator-blinded trial","volume":"40","author":"Liang S","year":"2025","unstructured":"Liang S, Shang S, Tan A, Zhang W, Zhou B, Mei X, Li L. Comparative efficacy and safety of the novel Picosecond Alexandrite Laser and the traditional combined Q-switched and long-pulse Nd: YAG lasers in melasma treatment: a randomized evaluator-blinded trial. Lasers Med Sci. 2025, 40:29. 10.1007\/s10103-025-04286-1","journal-title":"Lasers Med Sci"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.23312","article-title":"A prospective, split-face, randomized study comparing a 755-nm picosecond laser with and without diffractive lens array in the treatment of melasma in Asians","volume":"53","author":"Manuskiatti W","year":"2021","unstructured":"Manuskiatti W, Yan C, Tantrapornpong P, Cembrano KA, Techapichetvanich T, Wanitphakdeedecha R. A prospective, split-face, randomized study comparing a 755-nm picosecond laser with and without diffractive lens array in the treatment of melasma in Asians. Lasers Surg Med. 2021, 53:95-103. 10.1002\/lsm.23312","journal-title":"Lasers Surg Med"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.23615","article-title":"Combination of a 755-nm picosecond laser and hydroquinone 2% cream versus\u00a0hydroquinone 2% cream alone for the treatment of melasma: a randomized, split-face, and\u00a0controlled trial","volume":"54","author":"Manuskiatti W","year":"2022","unstructured":"Manuskiatti W, Yan C, Gulfan MC, Techapichetvanich T, Wanitphakdeedecha R. Combination of a 755-nm picosecond laser and hydroquinone 2% cream versus\u00a0hydroquinone 2% cream alone for the treatment of melasma: a randomized, split-face, and\u00a0controlled trial. Lasers Surg Med. 2022, 54:1245-50. 10.1002\/lsm.23615","journal-title":"Lasers Surg Med"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13537","article-title":"Micro-needling versus fractional carbon dioxide laser for delivery of tranexamic acid in the treatment of melasma: a split-face study","volume":"20","author":"Mekawy KM","year":"2021","unstructured":"Mekawy KM, Sadek A, Seddeik Abdel-Hameed AK. Micro-needling versus fractional carbon dioxide laser for delivery of tranexamic acid in the treatment of melasma: a split-face study. J Cosmet Dermatol. 2021, 20:460-5. 10.1111\/jocd.13537","journal-title":"J Cosmet Dermatol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000065","article-title":"Q-switched Nd: YAG laser versus trichloroacetic acid peeling in the treatment of melasma among Egyptian patients","volume":"40","author":"Moubasher AE","year":"2014","unstructured":"Moubasher AE, Youssef EM, Abou-Taleb DA. Q-switched Nd: YAG laser versus trichloroacetic acid peeling in the treatment of melasma among Egyptian patients. Dermatol Surg. 2014, 40:874-82. 10.1097\/DSS.0000000000000065","journal-title":"Dermatol Surg"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.21275\/SR231106233105","article-title":"A combination of low-fluence (1064 nm) Q-SND: YAG laser with topical 2% hydroquinone cream V\/S topical 2% hydroquinone cream for melasma in Indians-randomised controlled trial","volume":"12","author":"Navande SM","year":"2023","unstructured":"Navande SM, Kelkar A, Sardesai VR. A combination of low-fluence (1064 nm) Q-SND: YAG laser with topical 2% hydroquinone cream V\/S topical 2% hydroquinone cream for melasma in Indians-randomised controlled trial. IJSR. 2023, 12:851-5. 10.21275\/SR231106233105","journal-title":"IJSR"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2011.04150.x","article-title":"A randomized, observer-blinded, comparison of combined 1064-nm Q-switched neodymium-doped yttrium-aluminium-garnet laser plus 30% glycolic acid peel vs. laser monotherapy to treat melasma","volume":"36","author":"Park KY","year":"2011","unstructured":"Park KY, Kim DH, Kim HK, Li K, Seo SJ, Hong CK. A randomized, observer-blinded, comparison of combined 1064-nm Q-switched neodymium-doped yttrium-aluminium-garnet laser plus 30% glycolic acid peel vs. laser monotherapy to treat melasma. Clin Exp Dermatol. 2011, 36:864-70. 10.1111\/j.1365-2230.2011.04150.x","journal-title":"Clin Exp Dermatol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13992","article-title":"Clinical observation and dermoscopy evaluation of fractional CO(2) laser combined with topical tranexamic acid in melasma treatments","volume":"20","author":"Qu Y","year":"2021","unstructured":"Qu Y, Wang F, Liu J, Xia X. Clinical observation and dermoscopy evaluation of fractional CO(2) laser combined with topical tranexamic acid in melasma treatments. J Cosmet Dermatol. 2021, 20:1110-6. 10.1111\/jocd.13992","journal-title":"J Cosmet Dermatol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15970","article-title":"Comparison of 1064 nm Q-switched Nd:YAG laser and Jessner peeling in melasma treatment","volume":"35","author":"Ertam Sagduyu I","year":"2022","unstructured":"Ertam Sagduyu I, Marakli O, Oraloglu G, Bulut Okut E, Unal I. Comparison of 1064 nm Q-switched Nd:YAG laser and Jessner peeling in melasma treatment. Dermatol Ther. 2022, 35:e15970. 10.1111\/dth.15970","journal-title":"Dermatol Ther"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1111\/dsu.12060","article-title":"Oral tranexamic acid enhances the efficacy of low-fluence 1064-nm quality-switched neodymium-doped yttrium aluminum garnet laser treatment for melasma in Koreans: a randomized, prospective trial","volume":"39","author":"Shin JU","year":"2013","unstructured":"Shin JU, Park J, Oh SH, Lee JH. Oral tranexamic acid enhances the efficacy of low-fluence 1064-nm quality-switched neodymium-doped yttrium aluminum garnet laser treatment for melasma in Koreans: a randomized, prospective trial. Dermatol Surg. 2013, 39:435-42. 10.1111\/dsu.12060","journal-title":"Dermatol Surg"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.23032","article-title":"Assessment of combined fractional CO(2) and tranexamic acid in melasma treatment","volume":"51","author":"Tawfic SO","year":"2019","unstructured":"Tawfic SO, Abdel Halim DM, Albarbary A, Abdelhady M. Assessment of combined fractional CO(2) and tranexamic acid in melasma treatment. Lasers Surg Med. 2019, 51:27-33. 10.1002\/lsm.23032","journal-title":"Lasers Surg Med"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1080\/14764172.2017.1342036","article-title":"A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma","volume":"19","author":"Ustuner P","year":"2017","unstructured":"Ustuner P, Balevi A, Ozdemir M. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma. J Cosmet Laser Ther. 2017, 19:383-90. 10.1080\/14764172.2017.1342036","journal-title":"J Cosmet Laser Ther"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12854","article-title":"Low-fluence Q-switched Nd: YAG 1064-nm laser and intense pulsed light for the treatment of melasma","volume":"29","author":"Vachiramon V","year":"2015","unstructured":"Vachiramon V, Sirithanabadeekul P, Sahawatwong S. Low-fluence Q-switched Nd: YAG 1064-nm laser and intense pulsed light for the treatment of melasma. J Eur Acad Dermatol Venereol. 2015, 29:1339-46. 10.1111\/jdv.12854","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15934","article-title":"Prospective randomized controlled trial comparing treatment efficacy and tolerance of picosecond alexandrite laser with a diffractive lens array and triple combination cream in female asian patients with melasma","volume":"34","author":"Wang YJ","year":"2020","unstructured":"Wang YJ, Lin ET, Chen YT, et al.. Prospective randomized controlled trial comparing treatment efficacy and tolerance of picosecond alexandrite laser with a diffractive lens array and triple combination cream in female asian patients with melasma. J Eur Acad Dermatol Venereol. 2020, 34:624-32. 10.1111\/jdv.15934","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2009.01383.x","article-title":"Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians","volume":"36","author":"Wattanakrai P","year":"2010","unstructured":"Wattanakrai P, Mornchan R, Eimpunth S. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. Dermatol Surg. 2010, 36:76-87. 10.1111\/j.1524-4725.2009.01383.x","journal-title":"Dermatol Surg"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1002\/lsm.20937","article-title":"Non-ablative 1,550 nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled split-face study","volume":"42","author":"Wind BS","year":"2010","unstructured":"Wind BS, Kroon MW, Meesters AA, et al.. Non-ablative 1,550 nm fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled split-face study. Lasers Surg Med. 2010, 42:607-12. 10.1002\/lsm.20937","journal-title":"Lasers Surg Med"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-10129-4","article-title":"Novel melasma therapy using combined low fluence and microsecond pulse Q switched 1064\u00a0nm neodymium doped yttrium aluminium garnet laser","volume":"15","author":"Wu X","year":"2025","unstructured":"Wu X, Cen Q, Lin X, Shang Y, Wang X, Zhang Z. Novel melasma therapy using combined low fluence and microsecond pulse Q switched 1064\u00a0nm neodymium doped yttrium aluminium garnet laser. Sci Rep. 2025, 15:24596. 10.1038\/s41598-025-10129-4","journal-title":"Sci Rep"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000000057","article-title":"Combination treatment of low-fluence 1,064-nm Q-switched Nd: YAG laser with novel intense pulse light in Korean melasma patients: a prospective, randomized, controlled trial","volume":"40","author":"Yun WJ","year":"2014","unstructured":"Yun WJ, Moon HR, Lee MW, Choi JH, Chang SE. Combination treatment of low-fluence 1,064-nm Q-switched Nd: YAG laser with novel intense pulse light in Korean melasma patients: a prospective, randomized, controlled trial. Dermatol Surg. 2014, 40:842-50. 10.1097\/DSS.0000000000000057","journal-title":"Dermatol Surg"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.17795\/jssc30290","article-title":"Effect of hydroquinone plus neodymium-doped yttrium aluminium garnet laser with and without CO2 fractional laser on resistant dermal melasma","volume":"2","author":"Zamanian A","year":"2015","unstructured":"Zamanian A, Behrangi E, Ghafarpour GH, et al.. Effect of hydroquinone plus neodymium-doped yttrium aluminium garnet laser with and without CO2 fractional laser on resistant dermal melasma. J Skin Stem Cell. 2015, 2:30290. 10.17795\/jssc30290","journal-title":"J Skin Stem Cell"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.16432","article-title":"Safety and efficacy of a picosecond 755-nm alexandrite laser combined with topical tranexamic acid in the treatment of melasma","volume":"23","author":"Zhou N","year":"2024","unstructured":"Zhou N, Tao J, Yi Z, Wu L, Liu Z, Yang B. Safety and efficacy of a picosecond 755-nm alexandrite laser combined with topical tranexamic acid in the treatment of melasma. J Cosmet Dermatol. 2024, 23:3579-84. 10.1111\/jocd.16432","journal-title":"J Cosmet Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/473939-efficacy-and-safety-of-laser-based-therapies-for-melasma-a-systematic-review-and-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T22:37:16Z","timestamp":1774910236000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/473939-efficacy-and-safety-of-laser-based-therapies-for-melasma-a-systematic-review-and-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":78,"URL":"https:\/\/doi.org\/10.7759\/cureus.106154","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,30]]}}}